Morphine analgesic properties and side effects such as tolerance are mediated by the l opioid receptor (MOR) whose endocytosis is considered of primary importance for opioid pharmacological effects. Here, we show that p38 mitogen-activated protein kinase (MAPK) activation is required for MOR endocytosis and sufficient to trigger its constitutive internalization in the absence of agonist. Further studies established a functional link between p38 MAPK and the small GTPase Rab5, a key regulator of endocytosis. Expression of an activated mutant of Rab5 stimulated endocytosis of MOR ligand-independently in wild-type but not in p38aÀ/À cells. We found that p38a can phosphorylate the Rab5 effectors EEA1 and Rabenosyn-5 on Thr-1392 and Ser-215, respectively, and these phosphorylation events regulate the recruitment of EEA1 and Rabenosyn-5 to membranes. Moreover, phosphomimetic mutation of Thr-1392 in EEA1 can bypass the requirement for p38a in MOR endocytosis. Our results highlight a novel mechanism whereby p38 MAPK regulates receptor endocytosis under physiological conditions via phosphorylation of Rab5 effectors.
Introduction
Despite its powerful analgesic properties, morphine is almost only administrated in cases of intensive pain because of the development of adverse side effects, including respiratory depression, tolerance and dependence. Morphine acts through a seven-transmembrane G protein-coupled receptor (GPCR), called m opioid receptor (MOR) (Wang et al, 1994) . Studies using opioid receptor knockout mice have demonstrated that MOR mediates all morphine biological effects, both beneficial and adverse (Matthes et al, 1996; Kieffer, 1999) .
Agonist stimulation of MOR induces the activation of Gi/o proteins, including signals responsible for the analgesic effect, and can also trigger receptor internalization (Sternini et al, 1996; Law et al, 2000) , a process requiring G-proteinreceptor kinase(s) (GRK)-mediated phosphorylation of the receptor and recruitment of b-arrestin2 protein. The receptor is endocytosed via clathrin-coated vesicles and transported to early endosomes (Keith et al, 1998; Ferguson, 2001) . Two mechanisms have been envisaged to explain a possible role of MOR endocytosis in tolerance to morphine, defined as the decrease in drug efficacy with time (reviewed by Kieffer and Evans, 2002) . Tolerance could be caused by a reduction in the number of MORs at the plasma membrane. Alternatively, MOR endocytosis could be a protective process against the development of tolerance, which would be consistent with the failure of morphine to trigger MOR endocytosis despite potently inducing tolerance in vivo (Finn and Whistler, 2001; He et al, 2002) . The regulation of MOR endocytosis is, therefore, of primary importance for the understanding of opioid pharmacological effects.
Endocytic trafficking of plasma membrane receptors is regulated by monomeric small GTPases of the Rab family (Zerial and McBride, 2001) . Within this family, Rab5 is involved in endocytosis of several receptors, including GPCRs (reviewed by Seachrist and Ferguson, 2003) . Rab5 coordinates multiple processes, such as the formation of clathrin-coated vesicles, their fusion with early endosomes and homotypic early endosome fusion, as well as motility of endosomes along microtubules (Zerial and McBride, 2001) . As for other Rab GTPases, the activity of Rab5 is regulated via two overlapping cycles. First, Rab5 shuttles between the cytosol and the membrane, chaperoned by Rab GDP dissociation inhibitor (GDI) (Sasaki et al, 1990; Pfeffer et al, 1995) . Specific delivery to the membrane is catalyzed by GDI displacement factors that promote the dissociation of the Rab-GDI complex (Sivars et al, 2003) . Second, upon membrane delivery, Rab5 oscillates between the GDP-bound (inactive) and GTP-bound (active) forms (Rybin et al, 1996) regulated by GDP/GTP exchange factors (GEF) (Horiuchi et al, 1997) and GTPase-activating proteins (GAP) (Lanzetti et al, 2000) .
The fraction of GTP-bound Rab5 on the membrane is thus rate limiting for endosome dynamics (Rybin et al, 1996) . This activity is exerted through the interaction with effector proteins, including Rabaptin-5, phosphatidylinositol 3-kinases (PI3-K; VPS34/p150 and p85a/p110b), EEA1 and Rabenosyn-5 (Zerial and McBride, 2001 ). EEA1, one of the best-characterized Rab5 effectors, is involved in tethering/ docking and fusion of early endosomes (Mills et al, 1998; Simonsen et al, 1998; Christoforidis et al, 1999b) . EEA1 displays a complex modular architecture consisting of an N-terminal C 2 H 2 zinc-finger, which includes a Rab5-binding site, four heptad repeats and a C-terminal region containing a calmodulin-binding motif (IQ), a second Rab5-binding site and the C-terminal FYVE domain that specifically binds to phosphatidylinositol 3-phosphate (PI(3)P) (Mu et al, 1995; Patki et al, 1997; Simonsen et al, 1998) . Rab5 plays a dual role in the recruitment of EEA1, by direct interaction with the N-and C-terminal binding sites as well as by association with VPS34, the PI3-K that generates PI(3)P (Christoforidis et al, 1999b) . The mechanism of membrane recruitment of EEA1 is shared by Rabenosyn-5, which also contains a Rab5-binding domain and PI(3)P-binding FYVE finger (Nielsen et al, 2000) . EEA1 and Rabenosyn-5 are both necessary and play complementary roles in Rab5-dependent endosome tethering and fusion (Nielsen et al, 2000) .
Other recently established regulators of endocytosis are the p38 mitogen-activated protein kinases (MAPK), a family of Ser-Thr kinases that can regulate numerous cellular responses (reviewed by Nebreda and Porras, 2000) . The first evidence for a regulatory role of this signalling pathway in endocytosis was provided by the finding that, in the stressinduced response, p38a can phosphorylate Rab GDI, enhancing its activity in retrieving Rab5 from the membrane, with the consequent loss of EEA1 from early endosomes (Cavalli et al, 2001) . Endocytosis of AMPA receptors as well as phagolysosome biogenesis has been shown to be modulated by p38a (Fratti et al, 2003; Huang et al, 2004) . In this study, we discovered a new mechanistic role for p38a MAPK in endocytosis, centered on the regulation of membrane recruitment of Rab5 effectors.
Results

MOR endocytosis requires p38a MAPK
As long-term exposure to morphine has been reported to correlate with p38 MAPK activation (Ma et al, 2001; Singhal et al, 2002) , we investigated the function of this signalling pathway in MOR endocytosis. We established an HEK293 cell line expressing GFP-tagged MOR. These cells were stimulated by Damgo ([Tyr-DAla-Gly-MePhe-Gly-ol]enkephalin), a specific agonist of MOR, and activation of p38 MAPKs was examined by Western blotting using phospho-specific antibodies. In agreement with the absence of detectable endogenous MOR in these cells (data not shown), we found that Damgo was only able to induce p38 MAPK phosphorylation in HEK293 cells expressing GFP-MOR ( Figure 1A ). In contrast, p38 phosphorylation induced by UV treatment was independent of GFP-MOR expression. By immunoprecipitation followed by in vitro kinase assay, we confirmed that Damgo induced p38a MAPK activation ( Figure 1B ). The activation of p38a by Damgo was rapid and transient, with the kinase activity peaking after 5 min of stimulation. Quantitative assessment indicated that p38a activity levels upon Damgo stimulation were 8-16% of those obtained in UV-treated cells.
MOR endocytosis was investigated in GFP-MOR-expressing HEK293 cells by biotinylation of intact cells after Damgo stimulation, followed by the purification of biotinylated membrane proteins using avidin beads. In this assay, we detected a decrease in the amount of GFP-MOR associated with plasma membrane after 30 min of Damgo stimulation ( Figure 1C) , which was not due to degradation of the MOR receptor (Supplementary Figure S1) . MOR downregulation was confirmed by radioligand binding assays using 3 H-labelled Damgo, which showed an B40% decrease in Damgo-specific plasma membrane binding sites after 30 min of stimulation (see below).
Given the Damgo-induced p38 MAPK activation, we investigated the requirement for p38 MAPK activity in MOR internalization. First, the p38a and p38b inhibitor SB203580 strongly impaired the internalization of GFP-MOR in Damgostimulated cells ( Figure 1C ). Second, we used mouse embryonic fibroblasts (MEFs) from p38aÀ/À mice, which lack the most abundant p38 MAPK family member (Adams et al, 2000) . In agreement with previous studies (Nitsche and Pintar, 2003) , endogenous MOR was expressed in wild-type (wt) MEFs and only slightly reduced in p38aÀ/À MEFs ( Figure 1F ), as detected by Western blotting and radioligand binding assays ( Figure 1D , compare lanes 1 and 4). MEFs (wt and p38aÀ/À) were incubated with Damgo and plasma membrane expression of MOR was quantified in radioligand binding assays. Damgo stimulation decreased by about 70% the number of surface Damgo-binding sites in wt MEFs. In contrast, Damgo failed to induce any detectable endocytosis of endogenous MOR in p38aÀ/À MEFs, whereas expression of exogenous p38a in these cells restored endocytosis to about the same level as in wt cells ( Figure 1D ). Using primary MEFs derived from three different sets of littermate embryos, we confirmed that Damgo induced MOR internalization in wt but not in p38aÀ/À cells (data not shown). Altogether, the results demonstrate that Damgo-induced MOR endocytosis requires p38a MAPK.
Specific activation of p38 MAPKs induces constitutive MOR endocytosis
Having shown the requirement for p38 MAPK, we next investigated whether its activation was sufficient to induce MOR endocytosis. HEK293 cells expressing GFP-MOR were transfected to coexpress MKK6DD, a constitutively active form of the p38 MAPK activator MKK6 . MKK6DD expression resulted in higher levels of p38 MAPK phosphorylation both in untreated and Damgo-stimulated cells, without affecting MOR expression ( Figure 1E ). Interestingly, MKK6DD-expressing cells showed reduced levels of GFP-MOR plasma membrane expression in the absence of Damgo stimulation ( Figure 1C ). Moreover, stimulation with Damgo for 30 min resulted in the almost complete loss of GFP-MOR plasma membrane in MKK6DD-expressing cells ( Figure 1C ). By radioligand binding assays, we confirmed that expression of MKK6DD reduced by 40-70% the number of Damgo-binding sites on the plasma membrane in wt MEFs ( Figure 1D ) and increased Damgo-induced MOR endocytosis from 50 to 90% in GFP-MOR-expressing HEK293 cells (Figure 2A , lanes 2 and 5). The level of p38 MAPK phosphorylation in HEK293 cells transfected with MKK6DD varied between experiments, but there was good correlation between MKK6DD-induced p38 MAPK phosphorylation and MOR endocytosis ( Figure 1C and E versus Figure 2A and B).
To confirm the specificity of the above effect, we prevented the stimulatory activity of p38 MAPK using chemical inhibitors. Treatment of MKK6DD-expressing cells with SB203580 ( Figure 1C ) or PD169316 (data not shown) significantly increased the amount of GFP-MOR at the plasma membrane. Furthermore, expression of MKK6DD ( Figure 1G ) was unable to induce MOR endocytosis in p38aÀ/À MEFs ( Figure 1D , lane 6). These observations indicate that the constitutive endocytosis of MOR induced by MKK6DD is dependent on p38a activity.
Previous studies have reported that morphine is not able to trigger MOR endocytosis (Whistler and von Zastrow, 1998) and we obtained the same result in HEK293 cells expressing GFP-MOR (Figure 2A) . We found that, in contrast to Damgo, short-term exposure to morphine was not able to induce p38 MAPK activation ( Figure 2B ). We next investigated whether constitutive activation of p38 MAPKs could overcome the inability of morphine to trigger MOR endocytosis. Interestingly, morphine-induced MOR endocytosis was stimulated by the activation of p38 MAPKs upon expression of MKK6DD. Quantification by radioligand binding assays showed that upon morphine stimulation up to 75% of GFP-MOR was endocytosed after 30 min in cells expressing MKK6DD (Figure 2A , lane 6). We next extended our results to the neuroblastoma cell line SH-SY5Y, which can differentiate into cells with a neuronal phenotype and express endogenous MOR. In these neuronal cells, p38 MAPK activation was required for Damgo-induced MOR endocytosis ( Figure 2C ). Moreover, treatment of SH-SY5Y cells with 50 mM H 2 O 2 , a stress that moderately activates p38 MAPK (Supplementary Figure S2) , increased the rate of Damgo-induced MOR endocytosis and enabled also MOR endocytosis upon morphine treatment ( Figure 2C ). Taken together, our results show that constitutive activation of p38 MAPKs is sufficient to trigger MOR endocytosis, even in the absence of agonist stimulation or in the presence of morphine, which normally fails to induce MOR internalization.
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Rab5 is involved in Damgo induced-MOR endocytosis
The small GTPase Rab5 is a key regulator of transport in the early endocytic pathway (Zerial and McBride, 2001) and previous work has shown that a dominant-negative Rab5 mutant (Rab5-N133I) restores membrane expression of a MOR mutant, which is normally not detected at the plasma membrane (Li et al, 2001) . To determine whether p38 MAPK requires Rab5 activity in the regulation of MOR endocytosis, we transiently transfected HEK293 cells expressing GFP-MOR, either alone or together with MKK6DD, with the dominant-negative mutant Rab5S34N or with RN-tre, a Rab5 GAP (Lanzetti et al, 2000) . We found that either Rab5S34N or RN-tre markedly inhibited the constitutive (triggered by MKK6DD) as well as the Damgo-induced GFP-MOR internalization ( Figure 3A , compare lane 2 with lanes 6 and 10, and lanes 3 and 4 with lanes 7 and 8, and 11 and 12), without affecting p38 MAPK activation ( Figure 3B ). These results implicated Rab5 in the stimulation of MOR internalization by p38a MAPK.
Can the constitutively active mutant Rab5Q79L bypass the requirement for p38 MAPK in Damgo-induced MOR internalization? The effect of Rab5Q79L on MOR endocytosis was compared in wt and p38aÀ/À MEFs ( Figure 3C ). Expression of Rab5Q79L significantly decreased the level of plasma membrane-associated MOR only in wt but not in p38aÀ/À cells ( Figure 3C , compare lanes 2 and 5). The stimulation of MOR internalization observed in wt cells was abrogated upon treatment with SB203580 ( Figure 3C, lane 3) . Moreover, transfection of p38a into p38aÀ/À cells was able to rescue the ability of Rab5Q79L to induce constitutive (Damgoindependent) MOR endocytosis ( Figure 3C, lane 7) . Importantly, we did not observe any changes in the levels of p38 MAPK phosphorylation upon Rab5Q79L expression, either alone or in combination with Damgo ( Figure 3D) . Thus, the failure of Rab5Q79L to trigger MOR endocytosis in p38aÀ/À cells indicates an essential requirement for p38a in Rab5Q79L activity.
Regulation of EEA1 activity by p38a MAPK phosphorylation
Stress-induced activation of p38a can result in the phosphorylation of Rab GDI, enhancing its activity in retrieving Rab5 from the membrane (Cavalli et al, 2001) . However, the phosphorylation of Rab GDI by p38 MAPK and the consequent acceleration in the cycle of Rab5 membrane association/dissociation cannot, at least single-handedly, explain the effects of p38 MAPK on MOR endocytosis. The observation that increased levels of Rab5:GTP cannot promote endocytosis in p38aÀ/À cells argues that downstream effectors or regulators of Rab5 may be phosphorylated by p38 MAPK. To test this hypothesis, we screened for substrates of p38a among the Rab5 effectors and regulators, including the Rabaptin-5-Rabex-5 complex, EEA1, Rabenosyn-5 and the GAP RN-tre (TrH domain) (Zerial and McBride, 2001 ). Indeed, we found that the C-terminus of EEA1 (residues 1257-1411) and the full-length Rabenosyn-5 are both phosphorylated by p38a MAPK (Figure 4A and E). To identify the p38a phosphorylation site on EEA1, we first mutated several Ser and Thr residues located in the C-terminus to Ala. Mutation of Thr-1392, which is a canonical Ser/Thr-Pro MAPK phosphorylation site, to Ala abolished p38a-mediated phosphorylation of the EEA1 C-terminus ( Figure 4A ), whereas analogous mutations of Ser-1394 and Ser-1395 did not affect phosphorylation by p38a (data not shown). Using a phospho-threonine antibody that recognizes EEA1 phosphorylated on Thr-1392 ( Figure 4A , right panel), we confirmed the phosphorylation of endogenous EEA1 upon activation of p38 MAPKs by MKK6DD both in HEK293 cells and in SH-SY5Y neuronal cells ( Figure 4B ). Importantly, Damgo stimulation also induced the phosphorylation of endogenous EEA1, which was mediated by p38 MAPK, as indicated by the inhibitory effect of SB203580 in HEK293 cells expressing GFP-MOR and in the neuronal cell line SH-SY5Y ( Figure 4C ). However, EEA1 phosphorylation was not observed upon morphine stimulation ( Figure 4C, left panel) , providing a good correlation between p38 MAPK activation, EEA1 phosphorylation and MOR endocytosis. Interestingly, the C-terminus of EEA1 could efficiently be phosphorylated in vitro by 10-fold lower amounts of p38a than required for phosphorylating Rab GDI ( Figure 4D ).
The C-terminal fragment of EEA1 contains the PI(3)Pbinding FYVE domain (Stenmark et al, 2002) . Based on the EEA1 crystal structure (Dumas et al, 2001) , the p38 MAPK phosphorylation site lies within the FYVE domain dimer interface. The N-terminus of Rabenosyn-5 also includes an FYVE domain containing two p38 MAPK canonical phosphorylation sites (Nielsen et al, 2000; Stenmark et al, 2002) . Consistently, mutation of Ser-215 to Ala abolished p38 MAPKmediated phosphorylation of Rabenosyn-5 ( Figure 4E ), indicating that this is the major p38 MAPK phosphorylation site. Moreover, using a phospho-serine antibody, we confirmed the phosphorylation of endogenous Rabenosyn-5 upon activation of p38 MAPKs by MKK6DD in the neuronal cell line SH-SY5Y ( Figure 4F ). Since the FYVE domain of EEA1 is required for homodimerization, endosomal membrane localization and, consequently, activity in endosome fusion (Stenmark et al, 1996; Callaghan et al, 1999) , we first investigated whether Thr-1392 phosphorylation by p38a modulated the membrane recruitment of EEA1. The C-terminus of EEA1 either wt or containing the nonphosphorylatable mutation T1392A were in vitro translated and their ability to bind to isolated endosomal membranes was analyzed. Indeed, the EEA1 mutant T1392A was less efficiently recruited to endosomal membranes compared to wt EEA1 ( Figure 5A ). Quantitative analysis (Supplementary Figure S3) indicated that the recruitment of EEA1-T1392A was about 50% of the wt EEA1 value, both in the presence and absence of exogenous Rab5:GDI (the latter reflecting binding by the endogenous Rab5). The fact that EEA1-T1392A is still capable of membrane binding, albeit at reduced levels, is in agreement with multiple molecular interactions targeting EEA1 to endosomes (Simonsen et al, 1998; McBride et al, 1999; Lawe et al, 2003) .
In order to confirm in intact cells the results obtained using purified endosomal membranes, we transiently expressed full-length wt EEA1 and the corresponding mutants T1392A or T1392D (to mimic p38a phosphorylation) in wt and p38aÀ/À MEFs and determined their localization by both immunofluorescence microscopy analysis ( Figure 5B ) and subcellular fractionation ( Figure 5C ). In agreement with the in vitro experiments, EEA1-T1392A expressed in either wt or p38aÀ/À MEFs was also less efficiently recruited to endosomal membranes than wt EEA1. Interestingly, the T1392D mutation rescued to a large extent the membrane localization of EEA1. These results suggest that phosphorylation of Thr-1392 is required for the efficient recruitment of EEA1 to endosomal membranes in vivo. Surprisingly, in p38aÀ/À cells expressing wt EEA1, we observed small clusters of endosomes corresponding to tightly packed and tethered individual endosomes ( Figure 5B, panel 4, inset) . We estimated a frequency of about 14 clusters per p38aÀ/À cell versus not more than 1 per wt cell. Such a phenotype is reminiscent of the effects induced by the lack of EEA1 function in the conversion from membrane tethering to fusion (Christoforidis et al, 1999a; Lawe et al, 2002) . The T1392D mutation also partially restored EEA1 fusion activity, as assessed by a decreased number of clustered endosomes ( Figure 5B , panel 6; about 6 clusters/cell). Altogether, our results suggest that p38a MAPK-mediated phosphorylation enhances both EEA1 membrane localization and fusion activity.
We then investigated whether the Damgo-induced EEA1 phosphorylation correlated with membrane recruitment. Interestingly, Damgo increased the membrane recruitment of EEA1 in wt but not p38aÀ/À cells, indicating that Damgo-induced EEA1 membrane localization is strictly p38a dependent ( Figure 6A ). Moreover, incubation with SB203580 for 1 h reduced by about 25% the levels of membrane-localized EEA1 in wt cells, suggesting that p38a contributes to the regulation of membrane recruitment of EEA1 also in nonstimulated cells. Importantly, membrane recruitment of both EEA1 and Rabenosyn-5 was also increased, in a p38 MAPK-dependent manner, upon Damgo treatment of SH-SY5Y neuronal cells ( Figure 6B ).
As mentioned above, we have detected the presence of membrane-bound EEA1 in p38aÀ/À cells by immunofluorescence and immunoblotting ( Figure 5B and C) . To address the possible contribution of p38b MAPK activity to membrane localization of EEA1, we used siRNAs to knock down both p38a and p38b in HeLa cells. Remarkably, the downregulation of both p38 MAPKs resulted in a quantitative solubilization of endogenous EEA1 ( Figure 6C ). In a complementary experiment, HeLa cells were incubated with the p38a and p38b inhibitor SB203580 for 18 h. This long-term treatment resulted in a 50-75% solubilization of endogenous EEA1 and Rabenosyn-5 ( Figure 6D and Supplementary Figure  S4 ), confirming the involvement of the p38 MAPK family in membrane recruitment of these two Rab5 effectors.
To investigate the importance of EEA1 phosphorylation by p38a on Rab5-induced MOR endocytosis, we coexpressed Rab5Q79L together with different EEA1 mutants ( Figure 7A ). Expression in wt cells of EEA1 T1392A significantly inhibited Rab5Q79L-induced MOR endocytosis, whereas expression of wt EEA1 further potentiated it ( Figure 7B) . Importantly, the expression of EEA1T1392A also impaired Damgo-induced MOR endocytosis in wt cells, in the absence of Rab5Q79L expression ( Figure 7C ). These results confirm that phosphorylation on Thr-1392 affects EEA1 function. Strikingly, expression of EEA1 T1392D was able to bypass the requirement for p38a in Rab5Q79L-induced MOR endocytosis ( Figure 7B ). Moreover, overexpression of EEA1 T1392D alone ( Figure 7D ) was sufficient to induce some constitutive MOR endocytosis in p38aÀ/À cells, which was enhanced in the presence of either Damgo or morphine ( Figure 7C ). The ability of the EEA1 T1392D mutant to complement endogenous Rab5 activity in p38aÀ/À cells confirms an important role for EEA1 phosphorylation in the regulation of Rab5 function.
Discussion
In this study, we have established that p38 MAPKs play a key role in the modulation of MOR endocytosis. In the case of analgesic treatment, MOR activity upon chronic stimulation is the result of a balance between MOR signalling, which mediates the analgesic effect, and MOR endocytosis, which regulates tolerance (Finn and Whistler, 2001; He et al, 2002; Kieffer and Evans, 2002) . Thus, through the stimulation of MOR endocytosis, p38 MAPK is a primary candidate regulator of tolerance to morphine. Since p38aÀ/À mice are embryonic lethal (Adams et al, 2000) , the testing of this hypothesis should await the generation of conditional p38a knockout mice.
By investigating the molecular mechanisms that underlie MOR endocytosis, we have further uncovered an unexpected functional connection between p38 MAPK activity and the endocytic machinery regulated by the small GTPase Rab5. A role for p38 MAPKs in endocytosis has been previously proposed based on the ability of p38a to phosphorylate Rab GDI upon oxidative stress (Cavalli et al, 2001) . Surprisingly, our results indicate that p38 MAPK activity is also required under normal growth conditions to regulate ligand-dependent receptor stimulation and endocytosis. Cells respond to stress with very high levels of p38a activation. On the other hand, basal, low-level activity of p38a in nonstressed cells may have different functions, as postulated, for example, in the regulation of mRNA turnover (Ambrosino et al, 2003) . We propose that phosphorylation of EEA1 by p38a operates under physiological conditions to regulate the balance between soluble and membrane-bound Rab5 effectors. This housekeeping p38a function, however, is counteracted by the stress-induced hyperactivation of p38a, which is likely to result in the phosphorylation of additional p38 MAPK substrates, including Rab GDI. Consistent with this idea, we found that EEA1 is a better in vitro substrate for p38a than GDI, and MOR stimulation induces significantly lower levels of p38a activity than UV treatment. These results suggest that p38 MAPKs may play different mechanistic roles in endocytosis under basal versus stress or other stimulatory conditions via quantitative changes in activity on a spectrum of various substrates.
A genome-wide screen has recently uncovered a wider role of protein kinases in the regulation of endocytosis (Pelkmans et al, 2005) . Interestingly, silencing of several kinases by RNAi caused the accumulation of phosphorylated p38 MAPK on enlarged early endosomes. Our results provide a mechanistic explanation for the role of p38 MAPK on early endosomes, where it can phosphorylate effectors and regulators of the Rab5 machinery, thus modulating endocytosis depending on the level of activation.
It has been previously shown that the membrane recruitment of Rab5 effectors, such as EEA1, results from the additive contributions from multiple interactions (e.g. binding to Rab5:GTP, PI(3)P, Syntaxins, Ca 2 þ /calmodulin and oligomerization; Simonsen et al, 1998; McBride et al, 1999; Lawe et al, 2003) . Our results here suggest that p38 MAPKmediated phosphorylation is a new mechanism providing a regulatory function on the membrane recruitment and activity of Rab5 effectors, such as EEA1 and Rabenosyn-5. We showed that p38 MAPKs can phosphorylate EEA1 and Rabenosyn-5 on Thr-1392 and Ser-215, respectively. Interestingly, both phosphorylation sites are located within the FYVE finger, which by binding to PI(3)P plays an essential role in the recruitment of the proteins to the early endosome membrane. In the crystal structure of the EEA1 C-terminus, Thr-1392 lies in a region that has been implicated as FYVE domain dimer interface (Dumas et al, 2001) . Phosphorylation may thus be important for EEA1 binding to Rab5 or PI(3)P on the early endosome membrane, insertion of a hydrophobic loop into the membrane bilayer or electrostatic interactions (Hayakawa et al, 2004; Kutateladze et al, 2004) . This is consistent with the implication of amino acids 1365-1368 and 1392-1397 in the stabilization of EEA1 membrane docking (Hayakawa et al, 2004) . In summary, our results document a new and unexpected role for p38 MAPKs in the regulation of receptor endocytosis.
In showing that p38a can phosphorylate the Rab5 effectors EEA1 and Rabenosyn-5 and regulate their membrane binding, our data indicate that Rab5 effector activity is not only dependent on the so far established Rab5 regulatory cycles (membrane/cytosol and GTP/GDP) but can be also directly regulated by p38 MAPK phosphorylation. This is yet another example of coordinated regulation between signalling and membrane trafficking, expanding the repertoire of mechanisms that modulate receptor endocytosis.
Materials and methods
Cell culture and transfection
Primary MEFs were generated, cultured and immortalized by infection with SV40 large T-expressing retrovirus as previously described (Ambrosino et al, 2003; Porras et al, 2004) . HEK293 cells and MEFs were grown in Dulbecco's minimal essential medium (Gibco-BRL) supplemented with 10% heat-inactivated calf serum, 2 mM glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin at 371C and 5% CO 2 . Stably transfected HEK293-GFP-MOR cells were grown in medium supplemented with 1 mg/ml G-418 (Gibco-BRL) alone or together with 100 mg/ml of hygromycin (Gibco-BRL) for MKK6DD-expressing clones.
HEK293 cells were plated in 10 cm plates and 24 h later were transfected using the calcium phosphate method with either 10 mg of pcDNA3.1-GFP-MOR or the pcDNA3.1 vector (Invitrogene). The medium was changed 16 h post-transfection and the cells were incubated for another 48 h, before selection with 1 mg/ml of G-418. Single clones were screened for the expression of GFP-MOR by radioligand binding assay using 3 H-labelled Damgo (Amersham, Pharmacia). HEK293-GFP-MOR cells were cotransfected with 5 mg pEFmlink-MKK6DD or pEFmlink together with pcDNA3.1-hygro. Cells were selected with 100 mg/ml of hygromycin. Pools were selected for MKK6DD expression by Western blotting. HEK293 cells or MEFs were transiently transfected with 10 mg Rab5, Rab5Q79L or Myc-Rab5S34N in pCMV (Stenmark et al, 1994) , HA-RN-tre (Lanzetti et al, 2000) or EEA1 (de Renzis et al, 2002) in pcDNA3.1 or Myc-p38a in pEFmlink (Ambrosino et al, 2003) . MEFs were transiently transfected with either 1 or 10 mg of pEFmlink-MKK6DD, as indicated. Cells were collected 48 h after changing the transfection medium (see above) and used either for immunofluorescence and radioligand binding assays or to prepare cell lysates.
The neuroblastoma cell line SH-SY5Y was grown in Dulbecco's minimal essential medium (Gibco-BRL) supplemented with 10% heat-inactivated calf serum, 2 mM glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin at 371C and 5% CO 2 . All-trans retinoic acid (Sigma) was added every 2 days at a concentration of 10 mM during 6 days for SH-SH-5Y differentiation. For transfection experiments, cells were plated and 24 h later were transfected with 10 mg pEFmlink-MKK6DD or the pEFmlink vector using the Amaxa nucleofector system according to the manufacturer's instructions (Amaxa Biosystem). Cell lysates were prepared 48 h after the transfection. treated with UV using a Stratalinker apparatus and then incubated for 30 min . Preparation of cell lysates and Western blotting were performed as described previously (Ambrosino et al, 2003) . The primary antibodies were Phospho-p38 MAPK and Phospho-Thr (Cell Signalling Technologies), p38a (Santa-Cruz), Phospho-Ser (Abcam), a tubulin (Sigma), MOR (DiaSorin), MKK6 , Rab5 (Stenmark et al, 1994) , EEA1 (raised in rabbits against full-length EEA1 expressed in insect cells), Rabenosyn-5 (raised in rabbits against full-length Rabenosyn-5 expressed in insect cells and affinity purified) and Syntaxin-13 (McBride et al, 1999) . Binding of primary antibodies was detected using Alexa-680-coupled secondary antibodies and the Odyssey Imaging system (Ly-Cor). For the immunoprecipitation of endogenous EEA1 and Rabenosyn-5, HEK293-GFP-MOR and SH-SY5Y cells, expressing or not MKK6DD, were incubated for 30 min with 10 mM of either Damgo, morphine or SB203580.
Immunofluorescence
MEFs were grown on coverslips, transfected with wt EEA1 and the T1392A or T1392D mutants, fixed with 4% paraformaldehyde in PBS for 45 min at 41C and permeabilized with 4% Triton X-100. Saturation was performed using 5% BSA in PBS for 1 h at 41C. EEA1 was visualized using rabbit anti-EEA1 antibody, followed by incubation with secondary antibodies coupled to Alexa-488 (Molecular Probes). Images were taken with a Leica TCS SP2 confocal microscope.
Subcelullar fractionation
HeLa cells, MEFs and differentiated SH-SY5Y cells were transfected or stimulated as indicated, washed four times with ice-cold PBS, scraped and resuspended in swelling buffer (10 mM Tris pH 7.5, 10 mM KCl, 1.5 mM MgCl 2 , 0.25 M sucrose) containing phenylmethylsulfonyl fluoride (1 mM), leupeptin (10 mg/ml), pepstatin (10 mg/ml), sodium vanadate (1 mM) and aprotinin (10 mg/ml). Cells were lysed by repeated passages through a 27-gauge needle and the extracts were sequentially centrifuged first at 600 g for 12 min to remove nuclei and intact cells and then at 200 000 g for 1 h to separate the cytosol from the membranes.
Damgo binding assays
Cells were incubated for 30 min at 371C with Damgo or morphine (1 mM, unless indicated otherwise), and washed three times with medium for 5 min at 41C.
3 H-labelled Damgo binding (10 nM, 67 Ci/ mmol) was performed as described (Macé et al, 1999) . Nonspecific binding was determined in the presence of 1 mM of unlabelled Damgo. Experiments were performed in triplicate.
Site-directed mutagenesis
The EEA1 and Rabenosyn-5 mutants were generated with the QuickChange site-directed mutagenesis kit (Stratagene) using as templates pGEX-EEA1 (1257-1411), full-length EEA1 in pcDNA3.1 (de Renzis et al, 2002) and pGEX-Rabenosyn-5 (Nielsen et al, 2000) . All mutations were confirmed by DNA sequencing.
Recombinant protein purification
GST-human p38a, and MalE-MKK6DD , GST-EEA1 (1257-1411; wt and T1392A mutant) (Christoforidis et al, 1999a) , His-GDI and GST-Rabenosyn-5 (wt and S215A mutant) (Nielsen et al, 2000) were purified using either glutathione (GST), Talon (His) or amylose (MalE) beads from Escherichia coli BL21 (DE3) induced with isopropyl-1-thio-b-D-galactopyranoside.
p38 MAPK assays
Lysates prepared from Damgo-or UV-stimulated cells were incubated with rabbit anti-p38a antiserum coupled to protein A-Sepharose or with protein A-Sepharose alone overnight at 41C. The kinase assays were performed in the presence of [g-32 P]ATP (2 mCi) as described previously . Phosphorylated ATF2 was visualized by autoradiography.
Purified GST-p38a (1 mg, unless indicated otherwise) was activated with MalE-MKK6DD (200 ng) in 50 mM Tris-HCl, pH 7.5, 10 mM MgCl 2 , 2 mM DTT and 200 mM ATP for 1 h at 301C. Kinase assays were carried out using 200 ng of the active p38 MAPK in the same buffer as indicated above but containing 2 mM microcystin, 100 mM ATP and 2 mCi of [g-32 P]ATP for 30 min at 301C. The reaction was stopped by adding loading buffer and boiling for 5 min. Proteins were resolved by SDS-PAGE and detected by autoradiography.
In vitro recruitment assay of EEA1 on early endosomes Recruitment of EEA1 (1257-1411) wt and T1392A mutant to early endosomes was performed as described previously (Christoforidis et al, 1999b) using in vitro-translated EEA1 (TNT kit, Promega) and early endosomes purified from HeLa cells. Proteins bound to early endosomes were separated by SDS-PAGE and visualized by Western blotting and autoradiography.
Biotinylation and purification of cell surface proteins HEK293 cells expressing GFP-MOR alone or together with MKK6DD, MEFs and SH-SY5Y cells were grown to 80% confluency and incubated with 10 mM Damgo or morphine, 50 mM H 2 O 2 or 10 mM SB203580, as indicated. After four washes in PBS, cells were treated for 30 min at 41C with 0.4 mg/ml of membrane-impermeable sulfo-NHS-SS-Biotin (Pierce) prepared in PBS. Cells were then washed three times in PBS and lysed in a buffer containing 0.1% Triton X-100, 150 mM NaCl, 25 mM KCl and 10 mM Tris-HCl pH 7.4. The supernatants obtained after centrifugation at 10 000 g for 2 min were incubated with immobilized monomeric avidin according to the manufacturer's instructions (Pierce) to separate biotin-coupled cell surface proteins. After five washes in PBS, avidin-bound biotinylated proteins were resolved by SDS-PAGE and visualized by Western blotting.
Knockdown of p38a and p38b by siRNA Human p38a and p38b siRNAs and the control luciferase siRNA were obtained from Ambion. HeLa cells were transfected with 100 nM of siRNA using the siPORT transfection buffer (Ambion). After 96 h, cells were scraped and membranes were prepared as described above.
Supplementary data
Supplementary data are available at The EMBO Journal Online.
